158 related articles for article (PubMed ID: 20683973)
1. Antituberculosis therapy drug-induced liver injury and acute liver failure.
Devarbhavi H; Dierkhising R; Kremers WK
Hepatology; 2010 Aug; 52(2):798-9; author reply 799-800. PubMed ID: 20683973
[No Abstract] [Full Text] [Related]
2. [Fulminant hepatitis].
Yasuda H; Yoshiba S
Nihon Rinsho; 2007 Oct; 65 Suppl 8():545-8. PubMed ID: 18074599
[No Abstract] [Full Text] [Related]
3. [A case of the successful treatment of drug-induced toxic hepatitis in a child with tuberculous meningoencephalitis].
Kalugin AV; Kolesnikova IV; Zhuravleva LIu; Churiumova OG; Maĭorov VM
Anesteziol Reanimatol; 1998; (1):68-9. PubMed ID: 9553268
[No Abstract] [Full Text] [Related]
4. Impact of emergency adult living donor liver transplantation on the survival of patients with antituberculosis therapy-induced acute liver failure.
Huh JY; Lee D; Ahn J; Shim JH; Lim YS; Park GC; Song GW; Kim KH; Jung DH; Moon DB; Hwang S; Lee SG; Lee SW; Song JW; Oh YM; Shim TS; Jo KW
Liver Transpl; 2017 Jun; 23(6):845-846. PubMed ID: 28006868
[No Abstract] [Full Text] [Related]
5. Adverse reactions to antituberculosis drugs presenting as DRESS syndrome and acute liver failure.
Carlin Ronquillo A; Alvizuri Gómez C; García-Encinas C
Rev Gastroenterol Peru; 2022; 42(2):136-138. PubMed ID: 36513361
[TBL] [Abstract][Full Text] [Related]
6. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.
Ichai P; Saliba F; Antoun F; Azoulay D; Sebagh M; Antonini TM; Escaut L; Delvart V; Castaing D; Samuel D
Liver Transpl; 2010 Oct; 16(10):1136-46. PubMed ID: 20879012
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury.
Wang S; Shangguan Y; Ding C; Li P; Ji Z; Shao J; Fang H; Yang M; Shi P; Wu J; Ren J; Yang S; Yuan J; Shi Y; Li J; Li L; Xu K
J Int Med Res; 2020 Jan; 48(1):300060518811512. PubMed ID: 30477373
[TBL] [Abstract][Full Text] [Related]
8. Antituberculosis drug-induced hepatitis--the dangers of rechallenge.
Monteagudo FS; Pillans PI
S Afr Med J; 1986 Sep; 70(7):437-8. PubMed ID: 3764619
[No Abstract] [Full Text] [Related]
9. [A study of 172 patients with hepatic injury caused by antituberculosis drugs].
Cheng SQ
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):571. PubMed ID: 15387923
[No Abstract] [Full Text] [Related]
10. Side effects of antituberculosis therapy.
Resi D; Gagliotti C; Moro ML
Am J Respir Crit Care Med; 2004 Feb; 169(4):542; author reply 542. PubMed ID: 14766664
[No Abstract] [Full Text] [Related]
11. Side effects of antituberculosis drugs.
Mohan A; Sharma SK
Am J Respir Crit Care Med; 2004 Apr; 169(7):882-3. PubMed ID: 15044223
[No Abstract] [Full Text] [Related]
12. [Liver and antitubercular drug therapy].
Viroglio AL; Piñeyro JO; Acosta A; Munaro N; Escarguel Malbrán J; Pérez JA
Rev Fac Cienc Med Cordoba; 1974; 32(1):19-36. PubMed ID: 4458009
[No Abstract] [Full Text] [Related]
13. Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure.
Schneider R; Bercker S; Schubert S; Tillmann HL; Fangmann J; Hauss J; Bartels M
Transplant Proc; 2009 Nov; 41(9):3934-6. PubMed ID: 19917416
[TBL] [Abstract][Full Text] [Related]
14. [Hepatotoxicity caused by antituberculosis drugs in pediatrics].
Reto Valiente LV; Castillo Vergara J; Pichilingue Reto P; Pichilingue Prieto OA
Rev Gastroenterol Peru; 2005; 25(4):362-5. PubMed ID: 16333392
[TBL] [Abstract][Full Text] [Related]
15. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.
Devarbhavi H; Dierkhising R; Kremers WK; Sandeep MS; Karanth D; Adarsh CK
Am J Gastroenterol; 2010 Nov; 105(11):2396-404. PubMed ID: 20648003
[TBL] [Abstract][Full Text] [Related]
16. The dark side of antituberculosis therapy: adverse events involving liver function.
Schaberg T
Eur Respir J; 1995 Aug; 8(8):1247-9. PubMed ID: 7489784
[No Abstract] [Full Text] [Related]
17. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
Tiwari VK
J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
[No Abstract] [Full Text] [Related]
18. [Clinically apparent liver damage during brief tuberculosis therapy].
Estay S; Armas Merino R; Vega C; Soto JR
Rev Med Chil; 1981 Oct; 109(10):941-4. PubMed ID: 7344017
[No Abstract] [Full Text] [Related]
19. [Hepatotropic therapy in treatment of liver injury].
Sukhanov DS; Okovityĭ SV; Iablonskiĭ PK; Vinogradova TI; Pavlova MV
Antibiot Khimioter; 2012; 57(5-6):41-52. PubMed ID: 23156043
[TBL] [Abstract][Full Text] [Related]
20. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
